DuckWiseArchive › BNTX
BNTX trade ideas: every closed DuckWise idea on BioNTech SE
DuckWise has published 2 ideas on BioNTech SE (BNTX, Stock) that have closed between January 2021 and November 2021. Each is listed below with the levels published before the position was taken and its result at close — 2 in profit, 0 at a loss.
| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Nov 26, 2021 | Long | 281.94 | — | 334 | 350.57 | +24.34% | 24 |
| Jan 11, 2021 | Apr 16, 2021 | Long | 108.45 | — | 146.50 | 151.10 | +39.33% | 95 |
Prices in US dollars. Result is the price change from the published entry to the published close, before fees, taxes and slippage. How results are counted.
About BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. Does not pay dividends.
These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell BNTX or any other security.